2022
DOI: 10.1007/s12265-022-10303-3
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Effects of Salvianolic Acid B on Angiotensin II–Induced Atrial Fibrosis by Regulating Atrium Metabolism via Targeting AMPK/FoxO1/miR-148a-3p Axis

Abstract: The present study highlights the effects of salvianolic acid B (Sal B) on angiotensin II (Ang II)–activated atrial fibroblasts as well as the associated potential mechanism from the metabonomics perspective. Metabolic profile analysis performed an optimal separation of the Ang II and control group, indicating a recovery impact of Sal B on Ang II–activated fibroblasts (FBs). We found that metabolite levels in the Ang II + Sal B group were reversed to normal. Moreover, 23 significant metabolites were identified.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 49 publications
1
3
0
Order By: Relevance
“…Upregulated miR-148a-3p also opposed the IL-6-induced cytokine pathways and apoptotic cell death, as previously described in THP-1 macrophages stimulated with oxidized LDL [16]. Recently, upregulated miR-148a-3p has been associated with reduced oxidative stress in angiotensin II-activated atrial fibroblasts, retinal epithelial cells exposed to hyperglycemia, and both in vivo and in vitro ischemia/reperfusion models [55][56][57].…”
Section: Discussionsupporting
confidence: 61%
“…Upregulated miR-148a-3p also opposed the IL-6-induced cytokine pathways and apoptotic cell death, as previously described in THP-1 macrophages stimulated with oxidized LDL [16]. Recently, upregulated miR-148a-3p has been associated with reduced oxidative stress in angiotensin II-activated atrial fibroblasts, retinal epithelial cells exposed to hyperglycemia, and both in vivo and in vitro ischemia/reperfusion models [55][56][57].…”
Section: Discussionsupporting
confidence: 61%
“…Numerous studies on miR-148a-3p have revealed various downstream effects of modulating the levels or activities of miR-148a-3p. In addition to the promotion of angiogenesis, miR-148a-3p also inhibits the progression of malignancies such as hepatocellular carcinoma, lung cancer, and myeloid leukemia, besides exerting antifibrotic effects in pulmonary, liver, and atrial fibrosis. , Moreover, miR-148a-3p inhibits the inflammatory response and attenuates apoptosis in atherosclerosis to delay its progression. , The miR-148a-3p may also exert effects on skin wound healing by mediating other downstream effects and activating other signaling pathways, which requires further in-depth research.…”
Section: Discussionmentioning
confidence: 99%
“…The search for targeted therapy in CRC aimed at interfering with critical cell mechanisms such as cell growth and proliferation, angiogenesis, migration, and differentiation focuses on miRNA's ability to penetrate cells and inhibit target pathway(s), preventing cancer growth and causing apoptosis [43][44][45][46]. The capacity of miR-148a-3p to induce mitochondrial injury and aberrant ROS production has been reported in different cell models [56][57][58]. The results of this study provided the first evidence that overexpression of miR-148a-3p caused mitochondrial dysfunction along with oxidative stress, resulting in mitochondrial impairment and membrane depolarization in SW480 and SW620 cells.…”
Section: Discussionmentioning
confidence: 99%